Simcere Pharmaceutical Group Limited (2096.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
| Market Cap | 26.76B |
| Enterprise Value | 24.4B |
| P/E Ratio | 15.28 |
| PEG Ratio | 0.18 |
| Price/Sales Ratio | 2.69 |
| Price/Book Ratio | 2.2 |
| Enterprise/Revenue | 2.39 |
| Enterprise/EBITDA | 10.69 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.17 |
| Operating Margin | 0.2 |
| Return On Assets | 0.09 |
| Return On Equity | 0.16 |
| Revenue | 7.73B |
| Revenue/Share | 3.02 |
| Gross Profit | 6.31B |
| EBITDA | 1.72B |
| Net Income | 1.34B |
| Diluted EPS | 0.54 |
| Total Cash | 3.62B |
| Total Cash/Share | 1.41 |
| Total Debt | 1.2B |
| Total Debt/Equity | 0.13 |
| Current Ratio | 2.21 |
| Book Value Per Share | 3.68 |
| 52-Week Change | -16.58 |
| 52-Week High | 15.08 |
| 52-Week Low | 9.07 |
| Moving Average 50 Days | 11.32 |
| Moving Average 200 Days | 12.3 |
| Average Volume | 7.53M |
| Shares Outstanding | 2.57B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.18 |
| Trailing Annual Dividend Yield | 2.21 |
| Payout Ratio | 0.29 |
| Last Split Factor | N/A |
| Last Split Date | N/A |